Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
002518.SZ Stock Summary
Top 10 Correlated ETFs
002518.SZ
In the News
002518.SZ Financial details
Company Rating
Strong Buy
Market Cap
25.73B
Income
548.96M
Revenue
3.4B
Book val./share
5.58
Cash/share
2.87
Dividend
0.25
Dividend %
0.57%
Employees
2.92K
Optionable
No
Shortable
Yes
Earnings
28 Apr 2022
P/E
59.66
Forward P/E
-
PEG
7.76
P/S
9.73
P/B
7.92
P/C
15.39
P/FCF
88.73
Quick Ratio
0.87
Current Ratio
1.98
Debt / Equity
0.65
LT Debt / Equity
0
-
-
EPS (TTM)
0.92
EPS next Y
-
EPS next Q
-
EPS this Y
23.08%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
0%
Revenue last 5Y
0.55%
Revenue Q/Q
26.86%
EPS Q/Q
39.71%
-
-
-
-
SMA20
-16.09%
SMA50
-28.27%
SMA100
-21.78%
Inst Own
-
Inst Trans
-
ROA
8%
ROE
14%
ROC
0.15%
Gross Margin
31%
Oper. Margin
20%
Profit Margin
16%
Payout
33%
Shs Outstand
582.44M
Shs Float
215.42M
-
-
-
-
Target Price
-
52W Range
12.84-63.88
52W High
-29.87%
52W Low
+268.17%
RSI
40.82
Rel Volume
3.38
Avg Volume
12.53M
Volume
42.38M
Perf Week
0.98%
Perf Month
-17.03%
Perf Quarter
-1.82%
Perf Half Y
9.06%
-
-
-
-
Beta
0.05639
-
-
Volatility
1%, 3.86%
Prev Close
7.73%
Price
44.18
Change
6.97%
002518.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 4.7 | 4.72 | 4.48 | 4.16 | 4.81 | |
Net income per share | 0.64 | 0.4 | 0.55 | 0.52 | 0.64 | |
Operating cash flow per share | 0.69 | -0.16 | 1.69 | 0.64 | 0.77 | |
Free cash flow per share | 0.39 | -0.44 | 1.36 | 0.27 | 0.45 | |
Cash per share | 1.01 | 1.04 | 2.39 | 2.47 | 2.64 | |
Book value per share | 3.9 | 4.21 | 4.49 | 4.81 | 5.25 | |
Tangible book value per share | 3.82 | 4.1 | 4.39 | 4.55 | 4.92 | |
Share holders equity per share | 3.9 | 4.21 | 4.49 | 4.81 | 5.25 | |
Interest debt per share | 0 | 0.19 | 0.18 | 0.06 | 0.09 | |
Market cap | 8.79B | 3.89B | 5.95B | 6.66B | 14.48B | |
Enterprise value | 8.2B | 3.4B | 5.34B | 6.14B | 14.11B | |
P/E ratio | 23.66 | 16.91 | 18.57 | 21.96 | 38.8 | |
Price to sales ratio | 3.22 | 1.43 | 2.28 | 2.75 | 5.16 | |
POCF ratio | 22 | -43.38 | 6.05 | 17.78 | 32.14 | |
PFCF ratio | 38.77 | -15.33 | 7.49 | 41.59 | 55.79 | |
P/B Ratio | 3.88 | 1.61 | 2.27 | 2.37 | 4.73 | |
PTB ratio | 3.88 | 1.61 | 2.27 | 2.37 | 4.73 | |
EV to sales | 3.01 | 1.25 | 2.05 | 2.53 | 5.03 | |
Enterprise value over EBITDA | 18.16 | 10.88 | 12.61 | 15.21 | 28.75 | |
EV to operating cash flow | 20.54 | -37.87 | 5.43 | 16.39 | 31.34 | |
EV to free cash flow | 36.19 | -13.38 | 6.72 | 38.34 | 54.38 | |
Earnings yield | 0.04 | 0.06 | 0.05 | 0.05 | 0.03 | |
Free cash flow yield | 0.03 | -0.07 | 0.13 | 0.02 | 0.02 | |
Debt to equity | 0.68 | 0.46 | 0.55 | 0.47 | 0.6 | |
Debt to assets | 0.41 | 0.32 | 0.35 | 0.32 | 0.37 | |
Net debt to EBITDA | -1.29 | -1.58 | -1.44 | -1.29 | -0.74 | |
Current ratio | 2.22 | 2.67 | 2.31 | 2.42 | 1.99 | |
Interest coverage | 0 | 136.05 | 159.18 | 122.41 | 154.65 | |
Income quality | 1.08 | -0.39 | 3.07 | 1.24 | 1.21 | |
Dividend Yield | 0.01 | 0.03 | 0.02 | 0.02 | 0.01 | |
Payout ratio | 0.24 | 0.51 | 0.37 | 0.39 | 0.32 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Research and developement to revenue | 0.04 | 0.05 | 0.06 | 0.06 | 0.05 | |
Intangibles to total assets | 0.01 | 0.02 | 0.02 | 0.04 | 0.05 | |
Capex to operating cash flow | -0.43 | 1.83 | -0.19 | -0.57 | -0.42 | |
Capex to revenue | -0.06 | -0.06 | -0.07 | -0.09 | -0.07 | |
Capex to depreciation | -4.33 | -3.02 | -2.88 | -3.21 | -2.56 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 7.5 | 6.15 | 7.46 | 7.5 | 8.7 | |
ROIC | 0.25 | 0.19 | 0.22 | 0.16 | 0.14 | |
Return on tangible assets | 0.1 | 0.07 | 0.08 | 0.08 | 0.08 | |
Graham Net | -1.29 | -0.6 | 0.21 | 0.48 | 0.05 | |
Working capital | 1.64B | 1.55B | 1.64B | 1.64B | 1.65B | |
Tangible asset value | 2.22B | 2.36B | 2.56B | 2.65B | 2.87B | |
Net current asset value | 1.44B | 1.36B | 1.46B | 1.47B | 1.47B | |
Invested capital | 0 | 0.04 | 0.04 | 0.01 | 0.02 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 762.42M | 855.28M | 852.95M | 947.17M | 1.12B | |
Average inventory | 379.98M | 387.22M | 332.23M | 321.4M | 500.16M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 201.87 | 133.33 | 220.06 | 211.26 | 255.19 | |
Days of inventory on hand | 85.31 | 66.21 | 69.44 | 77.41 | 128.01 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 1.81 | 2.74 | 1.66 | 1.73 | 1.43 | |
Inventory turnover | 4.28 | 5.51 | 5.26 | 4.72 | 2.85 | |
ROE | 0.16 | 0.1 | 0.12 | 0.11 | 0.12 | |
Capex per share | -0.3 | -0.29 | -0.32 | -0.37 | -0.33 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
Metric | History | 2021-06-30 | 2021-09-30 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
---|---|---|---|---|---|---|
Revenue per share | 1.25 | 1.15 | 0.93 | 1.59 | 2.02 | |
Net income per share | 0.16 | 0.18 | 0.09 | 0.27 | 0.38 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0.05 | 0.1 | -0.38 | 0.18 | 0.68 | |
Cash per share | 2.29 | 2.28 | 2.19 | 2.18 | 2.87 | |
Book value per share | 5.02 | 5.19 | 5.17 | 5.2 | 5.58 | |
Tangible book value per share | 4.74 | 4.87 | 4.85 | 4.88 | 5.28 | |
Share holders equity per share | 5.02 | 5.19 | 5.17 | 5.2 | 5.58 | |
Interest debt per share | 0.08 | 0.08 | 0.09 | 0.14 | 0.14 | |
Market cap | 8.13B | 15.37B | 11.12B | 18.45B | 27.61B | |
Enterprise value | 7.65B | 14.99B | 10.66B | 17.81B | 26.85B | |
P/E ratio | 21.84 | 37.55 | 51.22 | 28.19 | 30.18 | |
Price to sales ratio | 11.34 | 23.38 | 19.84 | 19.21 | 22.66 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 265.01 | 278.33 | -49.07 | 168.75 | 67.79 | |
P/B Ratio | 2.83 | 5.17 | 3.57 | 5.89 | 8.21 | |
PTB ratio | 2.83 | 5.17 | 3.57 | 5.89 | 8.21 | |
EV to sales | 10.67 | 22.81 | 19.02 | 18.54 | 22.04 | |
Enterprise value over EBITDA | 69.2 | 123.17 | 162.43 | 94.85 | 96.58 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 249.49 | 271.49 | -47.05 | 162.88 | 65.93 | |
Earnings yield | 0.01 | 0.01 | 0 | 0.01 | 0.01 | |
Free cash flow yield | 0 | 0 | -0.02 | 0.01 | 0.01 | |
Debt to equity | 0.51 | 0.53 | 0.59 | 0.6 | 0.65 | |
Debt to assets | 0.34 | 0.34 | 0.37 | 0.37 | 0.39 | |
Net debt to EBITDA | -4.3 | -3.1 | -6.98 | -3.42 | -2.72 | |
Current ratio | 2.24 | 2.16 | 2.02 | 2.01 | 1.98 | |
Interest coverage | 295.18 | 163.4 | 152.41 | 512.57 | 155.74 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0.01 | 0 | 0 | 0.01 | 0 | |
Payout ratio | 1.26 | 0 | 0.01 | 0.9 | 0 | |
Sales general and administrative to revenue | -0.02 | 0.07 | 0.04 | -0.01 | 0.05 | |
Research and developement to revenue | 0.06 | 0.07 | 0.05 | 0.04 | 0.03 | |
Intangibles to total assets | 0.04 | 0.05 | 0.05 | 0.05 | 0.04 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | -0.06 | -0.1 | -0.07 | -0.03 | -0.03 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 4.29 | 4.57 | 3.23 | 5.63 | 6.9 | |
ROIC | 0.04 | 0.03 | 0.02 | 0.08 | 0.1 | |
Return on tangible assets | 0.02 | 0.02 | 0.01 | 0.03 | 0.04 | |
Graham Net | 0.19 | 0.09 | -0.07 | -0.17 | -0.05 | |
Working capital | 1.58B | 1.61B | 1.68B | 1.71B | 1.95B | |
Tangible asset value | 2.71B | 2.79B | 2.92B | 2.94B | 3.18B | |
Net current asset value | 1.4B | 1.43B | 1.51B | 1.53B | 1.75B | |
Invested capital | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 964.65M | 1.08B | 0 | 1.37B | 1.48B | |
Average inventory | 488.08M | 562.5M | 0 | 919.13M | 879.51M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 192.14 | 235.17 | 310.42 | 187.72 | 169.22 | |
Days of inventory on hand | 95.61 | 127.56 | 212.22 | 122.97 | 91.88 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0.47 | 0.38 | 0.29 | 0.48 | 0.53 | |
Inventory turnover | 0.94 | 0.71 | 0.42 | 0.73 | 0.98 | |
ROE | 0.03 | 0.03 | 0.02 | 0.05 | 0.07 | |
Capex per share | -0.07 | -0.12 | -0.06 | -0.06 | -0.05 |
002518.SZ Frequently Asked Questions
What is Shenzhen KSTAR Science and Technology Co., Ltd. stock symbol ?
Shenzhen KSTAR Science and Technology Co., Ltd. is a CN stock and trading under the symbol 002518.SZ
What is Shenzhen KSTAR Science and Technology Co., Ltd. stock quote today ?
Shenzhen KSTAR Science and Technology Co., Ltd. stock price is $44.18 today.
Is Shenzhen KSTAR Science and Technology Co., Ltd. stock public?
Yes, Shenzhen KSTAR Science and Technology Co., Ltd. is a publicly traded company.